Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T2DM With Inadequate Glycemic Control”

Showing 16 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT07055386
What this trial is testing

Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Gan & Lee Pharmaceuticals. 90
Large-scale testing (Phase 3)Study completedNCT02567994
What this trial is testing

Tenelia Triple Combination Study

Who this might be right for
Type 2 Diabetes Mellitus
Handok Inc. 201
Large-scale testing (Phase 3)UnknownNCT03851432
What this trial is testing

Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Sihuan Pharmaceutical Holdings Group Ltd. 390
Large-scale testing (Phase 3)Study completedNCT00337610
What this trial is testing

Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Merck Sharp & Dohme LLC 190
Large-scale testing (Phase 3)Ended earlyNCT04606576
What this trial is testing

Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Oramed, Ltd. 710
Post-approval studies (Phase 4)Study completedNCT02906709
What this trial is testing

Omarigliptin Add-on to Insulin in Japanese Participants With Type 2 Diabetes Mellitus (T2DM, MK-3102-039)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 184
Testing effectiveness (Phase 2)Study completedNCT03645421
What this trial is testing

Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 61
Large-scale testing (Phase 3)Not Yet RecruitingNCT06731075
What this trial is testing

Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus.

Who this might be right for
Type 2 Diabetes Mellitus
Oramed, Ltd. 300
Large-scale testing (Phase 3)Study completedNCT06571591
What this trial is testing

Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With Metformin

Who this might be right for
T2DM
Celltrion 606
Testing effectiveness (Phase 2)Study completedNCT03467932
What this trial is testing

Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Oramed, Ltd. 373
Large-scale testing (Phase 3)Study completedNCT01590797
What this trial is testing

A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 467
Not applicableStudy completedNCT02613897
What this trial is testing

ESR-15-11293 - Saxa/Dapa, Safety and Efficacy Study

Who this might be right for
Diabetes Mellitus, Type 2
The University of Texas Health Science Center at San Antonio 56
Large-scale testing (Phase 3)Study completedNCT01717313
What this trial is testing

Assess the Safety and Efficacy of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control (MK-3102-011)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 329
Large-scale testing (Phase 3)Study completedNCT01590771
What this trial is testing

A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 498
Large-scale testing (Phase 3)Study completedNCT01702298
What this trial is testing

Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 42
Large-scale testing (Phase 3)Not Yet RecruitingNCT07417306
What this trial is testing

HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 912

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation